Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Toxicon ; : 107825, 2024 Jun 20.
Article in English | MEDLINE | ID: mdl-38908526

ABSTRACT

Mushroom poisonings are common in the United States. Gyromitrin (acetaldehyde N-methyl-N-formylhydrazone) is a clinically significant mycotoxin primarily associated with the lorchel (i.e. the false morel) Gyromitra esculenta. Resemblance between 'true and false morels' has resulted in misidentification of Gyromitra spp. as edible and sought after Morchella spp., resulting in toxicity. Despite literature evidence outlining toxic sequalae, Gyromitra spp. mushrooms are commonly consumed and prepared for culinary purposes. Classic clinical teachings emphasize significant neurotoxicity, including seizures, associated with ingestion of gyromitrin-containing mushrooms, stemming from gyromitrin's terminal metabolite monomethylhydrazine. We performed a longitudinal descriptive review of the clinical toxicity associated with ingestion of mushroom species known or suspected to contain gyromitrin in cases reported to the Michigan Poison & Drug Information Center between January 1, 2002, to December 31, 2020. Our 19-year descriptive case series of gyromitrin-containing mushroom ingestions reported to our Center demonstrated a preponderance of gastrointestinal signs and symptoms, including hepatotoxicity. Of 118 identified cases, 108 (91.5%) of the reported ingestions involved Gyromitra esculenta. The most frequent clinical findings associated with symptomatic ingestions (n= 83) were the aforementioned gastrointestinal symptoms (n=62; 74.7%). Neurological symptoms were less frequent (n=22, 26.5%) while hepatotoxicity occurred in fewer patients (n=14; 16.9%). Of symptomatic patients, most were treated with symptomatic and supportive care (n=58; 70%). Pyridoxine was used in a total of seven patients (n=7; 8.4%) with either hepatotoxicity or neurotoxicity. Medical outcomes ranged from minor to major, with no reported deaths. Patient presentations (i.e. GI vs. neurotoxic symptoms) following ingestion of gyromitrin-containing mushrooms may be highly variable and multifactorial, owing to differences in dose ingested, geographical distribution, genetic variability of both patient and mushroom species, and species-specific differences in toxin composition. Future research warrants species-level identification of ingested gyromitrin-containing mushrooms and investigating the contribution of genetic polymorphisms to differences in clinical toxidromes.

3.
Eur Cell Mater ; 33: 143-157, 2017 02 14.
Article in English | MEDLINE | ID: mdl-28197990

ABSTRACT

Prevention of biomaterial-associated infections (BAI) remains a challenging problem, in particular due to the increased risk of resistance development with the current antibiotic-based strategies. Metallic orthopaedic devices, such as non-cemented implants, are often inserted under high mechanical stress. These non-cemented implants cannot be protected by e.g. antibioticreleasing bone cement or other antimicrobial approaches, such as the use of bioactive glass. Therefore, in order to avoid abrasion during implantation procedures, we developed an antimicrobial coating with great mechanical stability for orthopaedic implants, to prevent Staphylococcus aureus BAI. We incorporated 5 and 10 wt % chlorhexidine in a novel mechanically stable epoxy-based coating, designated CHX5 and CHX10, respectively. The coatings displayed potent bactericidal activity in vitro against S. aureus, with over 80 % of the release (19 µg/cm2 for CHX5 and 41 µg/cm2 for CHX10) occurring within the first 24 h. In mice, the CHX10 coating significantly reduced the number of CFU (colony forming units), both on the implants and in the peri-implant tissues, 1 d after S. aureus challenge. The CHX10-coated implants were well-tolerated by the animals, with no signs of toxicity observed by histological analysis. Moreover, the coating significantly reduced the frequency of culture-positive tissues 1 d, and of culture-positive implants 1 and 4 d after challenge. In summary, the chlorhexidine-releasing mechanically stable epoxy-based CHX10 coating prevented implant colonisation and S. aureus BAI in mice and has good prospects for clinical development.


Subject(s)
Biocompatible Materials/adverse effects , Chlorhexidine/therapeutic use , Coated Materials, Biocompatible/chemistry , Epoxy Compounds/chemistry , Prostheses and Implants/microbiology , Prosthesis-Related Infections/prevention & control , Staphylococcal Infections/prevention & control , Staphylococcus aureus/drug effects , Staphylococcus aureus/physiology , Titanium/chemistry , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Biopsy , Chlorhexidine/pharmacology , Drug Liberation , Mice, Inbred C57BL , Prosthesis-Related Infections/drug therapy , Prosthesis-Related Infections/microbiology , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology
4.
Acc Chem Res ; 44(9): 805-15, 2011 Sep 20.
Article in English | MEDLINE | ID: mdl-21766804

ABSTRACT

The structural complexity of molecules isolated from biological sources has always served as an inspiration for organic chemists. Since the first synthesis of a natural product, urea, chemists have been challenged to prepare exact copies of natural structures in the laboratory. As a result, a broad repertoire of synthetic transformations has been developed over the years. It is now feasible to synthesize organic molecules of enormous complexity, and also molecules with less structural complexity but prodigious societal impact, such as nylon, TNT, polystyrene, statins, estradiol, XTC, and many more. Unfortunately, only a few chemical transformations are so mild and precise that they can be used to selectively modify biochemical structures, such as proteins or nucleic acids; these are the so-called bioconjugation strategies. Even more challenging is to apply a chemical reaction on or in living cells or whole organisms; these are the so-called bioorthogonal reactions. These fields of research are of particular importance because they not only pose a worthy challenge for chemists but also offer unprecedented possibilities for studying biological systems, especially in areas in which traditional biochemistry and molecular biology tools fall short. Recent years have seen tremendous growth in the chemical biology toolbox. In particular, a rapidly increasing number of bioorthogonal reactions has been developed based on chemistry involving strained alkenes or strained alkynes. Such strained unsaturated systems have the unique ability to undergo (3 + 2) and (4 + 2) cycloadditions with a diverse set of complementary reaction partners. Accordingly, chemistry centered around strain-promoted cycloadditions has been exploited to precisely modify biopolymers, ranging from nucleic acids to proteins to glycans. In this Account, we describe progress in bioconjugation centered around cycloadditions of these strained unsaturated systems. Being among the first to recognize the utility of strain-promoted cycloadditions between alkenes and dipoles, we highlight our report in 2007 of the reaction of oxanobornadienes with azides, which occurs through a sequential cycloaddition and retro Diels-Alder reaction. We further consider the subsequent refinement of this reaction as a valuable tool in chemical biology. We also examine the development of the reaction of cyclooctyne, the smallest isolable cyclic alkyne, with a range of substrates. Owing to severe deformation of the triple bond from ideal linear geometry, the cyclooctynes show high reactivity toward dienes, 1,3-dipoles, and other molecular systems. In the search for bioorthogonal reactions, cycloadditions of cyclic alkenes and alkynes have now established themselves as powerful tools in reagent-free bioconjugations.


Subject(s)
Alkenes/chemistry , Alkynes/chemistry , Azides/chemistry , Catalysis , Copper , Cyclization , Nucleic Acids/chemistry , Proteins/chemistry
5.
Biomacromolecules ; 10(11): 3141-7, 2009 Nov 09.
Article in English | MEDLINE | ID: mdl-19839603

ABSTRACT

In this paper, we describe the controlled incorporation of two synthetic polymers with different structures in the cowpea chlorotic mottle virus (CCMV) capsid. Poly(ethylene glycol) (PEG) chains have been attached to the amine groups of lysine residues on the outer surface of the viral capsid. The functionalization of CCMV with PEG chains provoked a slow but irreversible dissociation of the virus into PEG-coat protein (CP) subunits, likely due to steric interference between the protein-protein subunits as a result of the presence of the PEG chains. This thermodynamic instability, however, can be overcome if a second polymer, such as polystyrene sulfonate (PSS), is present within the capsid. After complete disassembly of the PEG-CCMV conjugates and removal of the viral RNA, incubation of the PEG-functionalized coat proteins with PSS resulted in the formation of much more robust PSS-CCMV-PEG capsids with a diameter of 18 nm (T = 1 capsids). These are the first virus-like particles bearing synthetic organic polymers both inside and outside the viral capsid, opening a new route to the synthesis of biohybrid nanostructured materials based on viruses.


Subject(s)
Bromovirus/chemistry , Bromovirus/metabolism , Capsid Proteins/chemistry , Capsid/chemistry , Capsid/metabolism , Polymers/chemistry , Capsid Proteins/metabolism , Nanotechnology/methods , Polymers/chemical synthesis , Polymers/metabolism
6.
Bioconjug Chem ; 20(6): 1129-38, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19453101

ABSTRACT

The Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) has recently proven to be a powerful synthetic tool in various fields of chemistry, including protein-polymer conjugation. In this article, we describe a fluorogenic CuAAC, which allows for efficient monitoring of protein-polymer conjugation. We show that profluorescent 3-azido coumarin-terminated polymers can be reacted with an alkyne-functionalized protein to produce a strongly fluorescent triazole-linked conjugate. Upon formation of the product, the evolution of fluorescence can accurately be determined, providing information about the course of the CuAAC. As a proof of concept, we synthesized several 3-azido coumarin terminated poly(ethylene glycol) (PEG) chains and investigated their conjugation with alkyne-functionalized bovine serum albumin (BSA) as a model protein. CuAAC conjugation was shown to be very efficient and proceeded rapidly. Conversion plots were constructed from measuring the fluorescence as function of reaction time. An additional benefit of the fluorogenic CuAAC is the in situ labeling of bioconjugates. We envision that the fluorogenic protein-polymer conjugation is not restricted to the reaction system reported in this work, but may also be ideal to screen for optimal reaction conditions of various other systems.


Subject(s)
Alkynes/chemistry , Azides/chemistry , Copper/chemistry , Fluorescent Dyes/chemistry , Polymers/chemistry , Proteins/chemistry , Animals , Catalysis , Cattle , Coumarins/chemistry , Models, Molecular , Polyethylene Glycols/chemistry , Protein Binding , Serum Albumin, Bovine/chemistry
7.
Chembiochem ; 9(11): 1805-15, 2008 Jul 21.
Article in English | MEDLINE | ID: mdl-18623291

ABSTRACT

The tandem 1,3-dipolar cycloaddition-retro-Diels-Alder (tandem crDA) reaction is presented as a versatile method for metal-free chemoselective conjugation of a DTPA radiolabel to N-delta-azido-cyclo(-Arg-Gly-Asp-d-Phe-Orn-) via oxanorbornadiene derivatives. To this end, the behavior of several trifluoromethyl-substituted oxanorbornadiene derivatives in the 1,3-dipolar cycloaddition was studied and optimized to give a clean and efficient method for bio-orthogonal ligation in an aqueous environment. After radioisotope treatment, the resulting 111In-labeled c(RGD)-CF3-triazole-DTPA conjugate was subjected to preliminary biological evaluation and showed high affinity for alpha(v)beta(3) (IC(50)=192 nM) and favorable pharmacokinetics.


Subject(s)
Oligopeptides/chemical synthesis , Pentetic Acid/chemistry , Peptides, Cyclic/chemical synthesis , Triazoles/chemistry , Amino Acid Sequence , Integrin alphaVbeta3/metabolism , Metals/chemistry , Oligopeptides/chemistry , Oligopeptides/metabolism , Peptides, Cyclic/chemistry , Peptides, Cyclic/metabolism , Staining and Labeling
10.
Am J Physiol Regul Integr Comp Physiol ; 284(2): R474-80, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12388443

ABSTRACT

Mitochondria are chronically exposed to reactive oxygen intermediates. As a result, various tissues, including skeletal muscle and heart, are characterized by an age-associated increase in reactive oxidant-induced mitochondrial DNA (mtDNA) damage. It has been postulated that these alterations may result in a decline in the content and rate of production of ATP, which may affect tissue function, contribute to the aging process, and lead to several disease states. We show that with age, ATP content and production decreased by approximately 50% in isolated rat mitochondria from the gastrocnemius muscle; however, no decline was observed in heart mitochondria. The decline observed in skeletal muscle may be a factor in the process of sarcopenia, which increases in incidence with advancing age. Lifelong caloric restriction, which prolongs maximum life span in animals, did not attenuate the age-related decline in ATP content or rate of production in skeletal muscle and had no effect on the heart. 8-Oxo-7,8-dihydro-2'-deoxyguanosine in skeletal muscle mtDNA was unaffected by aging but decreased 30% with caloric restriction, suggesting that the mechanisms that decrease oxidative stress in these tissues with caloric restriction are independent from ATP availability. The generation of reactive oxygen species, as indicated by H2O2 production in isolated mitochondria, did not change significantly with age in skeletal muscle or in the heart. Caloric restriction tended to reduce the levels of H2O2 production in the muscle but not in the heart. These data are the first to show that an age-associated decline in ATP content and rate of ATP production is tissue specific, in that it occurs in skeletal muscle but not heart, and that mitochondrial ATP production was unaltered by caloric restriction in both tissues.


Subject(s)
Aging/physiology , Caloric Restriction , Energy Metabolism , Mitochondria/metabolism , Muscle, Skeletal/metabolism , Myocardium/metabolism , Adenosine Triphosphate/metabolism , Animals , Hydrogen Peroxide/metabolism , Male , Muscle, Skeletal/cytology , Myocardium/cytology , Rats , Rats, Inbred F344
11.
Behav Brain Res ; 123(1): 17-21, 2001 Aug 27.
Article in English | MEDLINE | ID: mdl-11377726

ABSTRACT

It has been shown before that unconditioned footshocks can augment the acoustic startle response in rats. In the present study, male mice of two strains, C57Bl/6N and BALB/c, were compared with regard to footshock-induced sensitization of the acoustic startle response. Presentation of footshocks did not affect the acoustic startle response in C57Bl/6N mice, while in contrast, footshock-induced sensitization was apparent in the BALB/c strain. Shocked C57Bl/6N mice, but not BALB/c mice, displayed robust conditioning to the startle context when re-tested the next day. These findings indicate that mice may exhibit footshock-induced sensitization of the acoustic startle response, but that the effects of footshocks on the acoustic startle are strain- and time-dependent.


Subject(s)
Reflex, Startle/physiology , Acoustic Stimulation , Animals , Defecation/physiology , Electroshock , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Species Specificity
12.
Hautarzt ; 52(3): 228-30, 2001 Mar.
Article in German | MEDLINE | ID: mdl-11284068

ABSTRACT

A 64-year old female patient was treated for a therapy-resistant generalized granuloma annulare with fumaric acid esters (Fumaderm initial). One week following begin of therapy with an initial dose of 30 mg per day, the papules had regressed significantly. A 6-week therapy with a final dose of 90 mg Fumaderm initial per day led to a nearly complete healing of the illness.


Subject(s)
Dermatologic Agents/therapeutic use , Fumarates/therapeutic use , Granuloma Annulare/drug therapy , Immunosuppressive Agents/therapeutic use , Dermatologic Agents/administration & dosage , Dimethyl Fumarate , Female , Follow-Up Studies , Fumarates/administration & dosage , Granuloma Annulare/pathology , Humans , Immunosuppressive Agents/administration & dosage , Middle Aged , Skin/pathology , Time Factors
13.
Int J Obes Relat Metab Disord ; 25(3): 378-88, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11319636

ABSTRACT

OBJECTIVE: To determine the mechanisms underlying the obesity-induced increase in myocardial lipid peroxidation in the fa/fa rat. We hypothesized that elevated heart work (ie rate-pressure product), an increased rate of superoxide (O2*-)) production, total myocardial lipid content, and/or insufficient antioxidant defenses are potential contributors to myocardial lipid peroxidation in obesity. DESIGN: Comparative, experimental study of myocardial tissue in 16-week-old lean control (Fa/?, normal diet), obese high-fat fed (Fa/?, 45% dietary fat), and obese fatty (fa/fa, normal diet) Zucker rats. MEASUREMENTS: Myocardial work (heart rate x systolic blood pressure), myocardial lipid content, oxidative and antioxidant enzyme activities (citrate synthase (CS), catalase (CAT), glutathione peroxidase (GPX), superoxide dismutase (SOD)), the rate of papillary muscle superoxide radical production in vitro, thiol content, basal and post-oxidative challenge myocardial lipid peroxidation levels using thiobarbituric reactive acid substances (TBARS) and lipid hydroperoxides (PEROX) as indices of lipid peroxidation. RESULTS: Compared to lean controls, the high-fat fed and fatty animals had similar elevations (P<0.05) in myocardial TBARS and PEROX (23%, 25% and 29% 45%, respectively; P<0.05), and elevated susceptibilities to oxidative stress in vitro following exposure to oxidizing agents (P<0.05). Resting heart work was slightly higher (P<0.05) in both the high-fat fed and fatty animals compared to controls. Myocardial lipid content, SOD activities and non-protein thiol (glutathione) levels were elevated (P<0.05) in high-fat fed and fatty animals compared to controls. The rate of superoxide formation by isolated papillary muscles in vitro did not differ among groups (P<0.05). Regression analysis revealed that the myocardial lipid content contributed most to myocardial lipid peroxidation (R2=0.76, P<0.05). CONCLUSIONS: Myocardial oxidative injury is closely associated with myocardial lipid content, but is not closely correlated with heart work, insufficient antioxidant defenses or a greater rate of superoxide production.


Subject(s)
Dietary Fats/administration & dosage , Lipid Peroxidation , Myocardium/metabolism , Obesity/metabolism , Animals , Lipid Peroxides/metabolism , Male , Rats , Rats, Zucker , Thiobarbituric Acid Reactive Substances/metabolism
14.
Behav Brain Res ; 118(2): 169-78, 2001 Jan 29.
Article in English | MEDLINE | ID: mdl-11164514

ABSTRACT

To investigate whether the hyperreactivity to mild environmental and novel stimuli in 5-HT1B receptor knockout (1BKO) mice, as suggested by measures of exploratory, aggressive, and impulsive behaviors, can be extended to phasic stimuli, 1BKO and wildtype mice were tested in acoustic startle reactivity and plasticity paradigms, including habituation, prepulse inhibition, and footshock-induced sensitization of the startle response. Furthermore, we compared 5-HT1A receptor knockout (1AKO) and 1BKO mice to further test the suggested opposite behavioral profiles in these two genotypes. Results show that startle reactivity and footshock-induced sensitization was reduced in 1BKO mice, with no changes in habituation or PPI. In contrast, 1AKO mice did not differ from WT mice in any of the measures. These results indicate that an absence of 5-HT1B receptors, but not of 5-HT1A receptors, affects the modulation of startle reactivity and footshock-induced sensitization, without influencing startle plasticity. Moreover, this study suggests that 1AKO mice display a distinct, but not opposite behavioral profile from 1BKO mice. Furthermore, it is concluded that the hyperreactivity in 1BKO mice cannot be generalized to all stimuli, including the startling stimuli used in this study, but is probably restricted to mild environmental stimuli only.


Subject(s)
Electroshock , Receptors, Serotonin/genetics , Reflex, Startle/genetics , Acoustic Stimulation , Animals , Body Weight/physiology , Genotype , Habituation, Psychophysiologic , Male , Mice , Mice, Knockout , Receptor, Serotonin, 5-HT1B , Receptors, Serotonin, 5-HT1
15.
Neuroreport ; 11(10): 2285-8, 2000 Jul 14.
Article in English | MEDLINE | ID: mdl-10923686

ABSTRACT

In a previous study it was demonstrated that flesinoxan, a selective serotonin (5-HT)1A receptor agonist, had anxiolytic properties in the fear-potentiated startle paradigm. The present study investigated the putative site of action of flesinoxan in this paradigm. Flesinoxan infused either into the dorsal raphe nucleus or the median raphe nucleus did not affect startle potentiation. Bilateral infusion of flesinoxan into the central nucleus of the amygdala on the other hand, dose-dependently blocked the fear-potentiated startle response. These data indicate that flesinoxan exerts it anxiolytic effects in the fear-potentiated startle paradigm via the central nucleus of the amygdala, whereas the dorsal and median raphe nuclei are not directly involved in this process.


Subject(s)
Amygdala/physiology , Anti-Anxiety Agents/pharmacology , Fear , Piperazines/pharmacology , Raphe Nuclei/physiology , Reflex, Startle/drug effects , Amygdala/drug effects , Animals , Anti-Anxiety Agents/administration & dosage , Dose-Response Relationship, Drug , Functional Laterality , Infusions, Parenteral , Male , Piperazines/administration & dosage , Raphe Nuclei/drug effects , Rats , Rats, Wistar , Receptors, Serotonin/physiology , Receptors, Serotonin, 5-HT1 , Reflex, Startle/physiology
18.
Psychopharmacology (Berl) ; 149(3): 277-85, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10823409

ABSTRACT

RATIONALE: Young rodents emit ultrasonic vocalizations (USVs) when separated from their dams and littermates. Pharmacological agents that act on GABA(A) and/or 5-HT receptors and that alleviate anxiety in humans reduce the emission of these calls. OBJECTIVES: 1) to investigate specific 5-HT1 receptor subtypes that modulate maternal separation-induced USVs in mice; 2) to assess the behavioral specificity of these effects; and 3) to compare 5-HT1 agonists with a positive neurosteroid modulator of the GABA(A) receptor complex. METHODS: Seven-day old CFW mouse pups were isolated from their littermates and placed onto a 20 degrees C surface for 4 min. USVs between 30 and 80 kHz, grid crossing, and rectal temperature were measured in separate groups of mouse pups following subcutaneous administration of 5-HT1A and 5-HT1B receptor agonists and antagonists, the neurosteroid allopregnanolone, or the benzodiazepine midazolam. RESULTS: The 5-HT1A agonists (+)8-OH-DPAT (0.01-0.1 mg/kg) and flesinoxan (0.3-1.0 mg/kg), the selective 5-HT1B agonist CP-94,253 (0.03-30.0 mg/kg), and the mixed 5-HT1B/2C receptor agonist TFMPP (0.1-10.0 mg/kg) dose-dependently reduced USVs. These effects were reversed by the 5-HT1A receptor antagonist WAY 100,635 (0.1 mg/kg) or the 5-HT1B/D receptor antagonist GR 127935 (0.1 mg/kg). The effects of TFMPP were biphasic; low doses (i.e. 0.01 and 0.03 mg/kg) increased the rate of vocalization. Midazolam and allopregnanolone also reduced USVs. The highest doses of flesinoxan, (+)8-OH-DPAT, and allopregnanolone suppressed locomotion, whereas CP-94,253, TFMPP, and midazolam stimulated motor activity. CONCLUSIONS: These experiments confirm that agonists at the 5-HT1 receptors and a positive allosteric modulator of the GABA(A) receptor complex decrease maternal separation-induced USVs in mice, with 5-HT1B manipulations dissociating the effects on vocalizations from sedative effects.


Subject(s)
GABA Modulators/pharmacology , Receptors, GABA-A/drug effects , Receptors, Serotonin/drug effects , Serotonin Receptor Agonists/pharmacology , Vocalization, Animal/drug effects , Animals , Animals, Newborn , Drug Evaluation, Preclinical , Female , Male , Maternal Deprivation , Mice , Receptor, Serotonin, 5-HT1B , Receptors, GABA-A/physiology , Receptors, Serotonin/physiology , Receptors, Serotonin, 5-HT1 , Ultrasonics , Vocalization, Animal/physiology
19.
Neuroreport ; 11(18): 4097-102, 2000 Dec 18.
Article in English | MEDLINE | ID: mdl-11192635

ABSTRACT

Relative to wildtype mice, mice lacking 5-HT1B receptors (5-HT1B KO) exhibit exaggerated heart rate and body temperature responses to environmental stimuli. In contrast, acoustic startle reactivity is reduced in 5-HT1B KO mice. We combined heart rate and temperature measurement with startle response paradigms in order to elucidate this apparent contradiction. Habituation and footshock-induced sensitization paradigms modulate startle reactivity. Reduced startle reactivity and unaltered habituation in 5-HT1B KO mice were replicated. Heart rate and temperature were unaffected by startle stimuli, but increased markedly in response to transportation and handling procedures. Footshocks caused a mild startle-sensitization and tachycardia in both genotypes. The physiological hyper-reactivity in 5-HT1B KO mice is a subtle phenotypic difference that contrasts with the phenotypic decrease in startle reactivity.


Subject(s)
Body Temperature/genetics , Brain/metabolism , Heart Rate/genetics , Mice, Knockout/physiology , Receptors, Serotonin/deficiency , Reflex, Startle/genetics , Acoustic Stimulation/adverse effects , Adaptation, Physiological/genetics , Animals , Behavior, Animal/physiology , Brain/cytology , Electric Stimulation/adverse effects , Habituation, Psychophysiologic/physiology , Male , Mice , Phenotype , Receptor, Serotonin, 5-HT1B , Receptors, Serotonin/genetics
20.
Res Exp Med (Berl) ; 197(3): 125-35, 1997.
Article in English | MEDLINE | ID: mdl-9406280

ABSTRACT

The specific cholecystokinin (CCK) receptor antagonist loxiglumide has been used in several human and animal studies to investigate the role of CCK in gastrointestinal physiology. In the present study, the interference of this CCK receptor antagonist with hepatic transport processes was characterized in the perfused rat liver. Indocyanine green, an organic dye which is secreted into bile without being metabolized, was taken up in control experiments at a rate of 68.1 +/- 7.7%. The CCK receptor antagonist lowered the extraction to 0.5 +/- 2.6% (P < 0.001). The compound diminished the hepatic extraction of CCK-8 from 90.95 +/- 2.60% to 4.90 +/- 1.95% (P < 0.001) and of gastrin from 22.2 +/- 1.1% to 8.2 +/- 1.9% (P < 0.001). The hepatic extraction of lidocaine, which is metabolized by the cytochrome P450 system, was only slightly altered. For leukotrienes and taurocholate, the rate-limiting step for transport into bile is secretion across the canalicular membrane; the hepatic extraction of leukotriene D4 was markedly diminished by loxiglumide whereas the transport of taurocholate was only slightly inhibited. The present study demonstrates that the specific CCK receptor antagonist loxiglumide diminished the hepatic extraction of various substances, including peptides and organic anions. It did not interfere with the cytochrome P450 system. The pronounced reduction of hepatic uptake of indocyanine green and leukotriene may be due to an interference with the transport system of these substances in the liver.


Subject(s)
Hormone Antagonists/pharmacology , Liver/metabolism , Proglumide/analogs & derivatives , Receptors, Cholecystokinin/metabolism , Animals , Bile/chemistry , Biological Transport/drug effects , Cholagogues and Choleretics/pharmacology , Gastrins/analysis , Gastrins/metabolism , Indocyanine Green/pharmacokinetics , Leukotriene D4/pharmacology , Liver/blood supply , Liver/drug effects , Male , Portal Vein , Proglumide/pharmacology , Rats , Rats, Wistar , Receptors, Cholecystokinin/agonists , Receptors, Cholecystokinin/antagonists & inhibitors , Sincalide/analysis , Sincalide/metabolism , Taurocholic Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL